Securities code: Shanghai Pharmaceuticals Holding Co.Ltd(601607) securities abbreviation: Shanghai Pharmaceuticals Holding Co.Ltd(601607) Announcement No.: pro 2022033 Shanghai Pharmaceuticals Holding Co.Ltd(601607)
Announcement on postponement of 2021 annual performance presentation meeting
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Shanghai Pharmaceuticals Holding Co.Ltd(601607) (hereinafter referred to as “the company”) disclosed the announcement on holding the 2021 annual performance presentation meeting (p.2022021) on March 29, 2022. In order to support the fight against the epidemic and implement the epidemic prevention requirements, the 2021 annual performance presentation originally scheduled for 9:30-10:30 a.m. on Wednesday, March 30, 2022 will be postponed, and the specific date will be announced separately.
The Company Apologizes for the changes brought to investors. Please understand.
It is hereby announced.
Shanghai Pharmaceuticals Holding Co.Ltd(601607) board of directors
March 30, 2022
